Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: A systematic review and meta-analysis

Liver Transplantation

Volumn 20, Issue 4, 2014, Pages 425-436

  Wan, Ping ^a   Yu, Xin ^b   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL BLEEDING; ARTICLE; BILIARY TRACT DISEASE; COLD ISCHEMIA; COLD ISCHEMIA TIME; DECEASED DONOR; ERYTHROCYTE TRANSFUSION; HUMAN; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONOR; META ANALYSIS; OPERATION DURATION; ORGAN DONOR; OUTCOMES RESEARCH; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETRANSPLANTATION; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ADOLESCENT; ADULT; AGED; CHILD; COMPARATIVE STUDY; INFANT; LIVER FAILURE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES; REOPERATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; LENGTH OF STAY; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896920448     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23836     Document Type: Article

References (39)

1. Thuluvath PJ, Yoo HY,. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004; 10: 1263-1268.
2. Abt PL, Mange KC, Olthoff KM, Markmann JF, Reddy KR, Shaked A,. Allograft survival following adult-to-adult living donor liver transplantation. Am J Transplant 2004; 4: 1302-1307.
3. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R; for United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7-15.
4. Wiesner RH, Freeman RB, Mulligan DC,. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004; 127 (suppl 1): S261-S267.
5. Berg CL, Merion RM, Shearon TH, Olthoff KM, Brown RS Jr, Baker TB, et al. Liver transplant recipient survival benefit with living donation in the Model for Endstage Liver Disease allocation era. Hepatology 2011; 54: 1313-1321.
6. Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, et al. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes. Transpl Int 2013; 26: 780-787.
7. Fisher RA, Cotterell AH, Maluf DG, Stravitz RT, Ashworth A, Nakatsuka M, et al. Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experience. Ann Hepatol 2009; 8: 298-307.
8. Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, et al. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study consortium. Liver Transpl 2013; 19: 259-267.
9. Stang A,. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
10. Moher D, Liberati A, Tetzlaff J, Altman DG,; for PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
11. Hozo SP, Djulbegovic B, Hozo I,. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005; 5: 13.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
13. Garcia-Retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004; 40: 699-707.
14. Van Vlierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B,. Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 2004; 77: 210-214.
15. Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H Jr, et al. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005; 42: 1420-1428.
16. Liu CL, Fan ST, Lo CM, Wei WI, Chan SC, Yong BH, Wong J,. Operative outcomes of adult-to-adult right lobe live donor liver transplantation: a comparative study with cadaveric whole-graft liver transplantation in a single center. Ann Surg 2006; 243: 404-410.
17. Shah SA, Levy GA, Greig PD, Smith R, McGilvray ID, Lilly LB, et al. Reduced mortality with right-lobe living donor compared to deceased-donor liver transplantation when analyzed from the time of listing. Am J Transplant 2007; 7: 998-1002.
18. Al-Sebayel M, Khalaf H, Al-Sofayan M, Al-Saghier M, Abdo A, Al-Bahili H, et al. Experience with 122 consecutive liver transplant procedures at King Faisal Specialist Hospital and Research Center. Ann Saudi Med 2007; 27: 333-338.
19. Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P,. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl 2007; 13: 687-692.
20. Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, et al. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl 2008; 14: 1778-1786.
21. Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, et al.; for A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL retrospective cohort study. Am J Transplant 2008; 8: 2569-2579.
22. Gõmez CM, Dumonceau JM, Marcolongo M, de Santibañes E, Ciardullo M, Pekolj J, et al. Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation. Transplantation 2009; 88: 1280-1285.
23. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, et al. Natural history of post-liver transplantation hepatitis C: a review of factors that may influence its course. Liver Transpl 2009; 15: 1872-1881.
24. Lai JC, Pichardo EM, Emond JC, Brown RS Jr,. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. Am J Transplant 2009; 9: 586-591.
25. Shin YH, Yu SK, Kwon CH, Ko JS, Gwak MS, Kim GS,. The comparison of the perioperative changes in lactate and prothrombin time between deceased versus living donor liver transplantation. Transplant Proc 2010; 42: 4151-4153.
26. Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, et al.; for A2ALL Study Group. Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation. Ann Surg 2010; 251: 542-549.
27. Li C, Mi K, Wen TF, Yan Ln, Li B, Yang JY, et al. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One 2011; 6: e27366.
28. Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS,. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up. Transplantation 2011; 92: 453-460.
29. Jiang L, Yan L, Tan Y, Li B, Wen T, Yang J, Zhao J,. Adult-to-adult right-lobe living donor liver transplantation in high Model for End-Stage Liver Disease score recipients with hepatitis B virus-related benign liver diseases. Surg Today 2013; 43: 1039-1048.
30. Lo CM,. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 2003; 75 (suppl): S12-S15.
31. Lee SG,. Asian contribution to living donor liver transplantation. J Gastroenterol Hepatol 2006; 21: 572-574.
32. Berg CL, Gillespie BW, Merion RM, Brown RS Jr, Abecassis MM, Trotter JF, et al.; for A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007; 133: 1806-1813.
33. Kim SJ, Yoon YC, Yoo YK, Park JH, Kim DG,. Clinical analysis of emergency liver transplantation: the role of living donor liver transplantation. Clin Transplant 2012; 26: 833-841.
34. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, et al. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011; 53: 1570-1579.
35. Roayaie K, Feng S,. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Liver Transpl 2007; 13 (suppl 2): S36-S43.
36. Chan SC, Fan ST, Lo CM, Liu CL, Wei WI, Chik BH, Wong J,. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg 2008; 248: 411-419.
37. Hwang S, Lee SG, Sung KB, Park KM, Kim KH, Ahn CS, et al. Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation. Liver Transpl 2006; 12: 831-838.
38. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA,. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322: 1505-1507.
39. Surman OS,. The ethics of partial-liver donation. N Engl J Med 2002; 346: 1038.